APA (7th ed.) Citation

Cabrera-Pérez, L. C., Padilla-Martínez, I. I., Miliar-García, Á., Gómez-López, M., Franco-Hernández, M. O., Mendieta-Wejebe, J. E., & Rosales-Hernández, M. C. (2026). Ex vivo and in silico evaluations of (E)-5-((benzo[d]thiazol-2-ylimino)(methylthio)methylamino)-2-hydroxybenzoic acid as a β3-adrenoreceptor agonist exerting anti-obesity, anti-inflammatory and hepatoprotective effects on Zucker rats. PLoS ONE, 21(3), 1. https://doi.org/10.1371/journal.pone.0344359

Chicago Style (17th ed.) Citation

Cabrera-Pérez, Laura Cristina, Itzia Irene Padilla-Martínez, Ángel Miliar-García, Modesto Gómez-López, Marina Olivia Franco-Hernández, Jessica Elena Mendieta-Wejebe, and Martha Cecilia Rosales-Hernández. "Ex Vivo and in Silico Evaluations of (E)-5-((benzo[d]thiazol-2-ylimino)(methylthio)methylamino)-2-hydroxybenzoic Acid as a β3-adrenoreceptor Agonist Exerting Anti-obesity, Anti-inflammatory and Hepatoprotective Effects on Zucker Rats." PLoS ONE 21, no. 3 (2026): 1. https://doi.org/10.1371/journal.pone.0344359.

MLA (9th ed.) Citation

Cabrera-Pérez, Laura Cristina, et al. "Ex Vivo and in Silico Evaluations of (E)-5-((benzo[d]thiazol-2-ylimino)(methylthio)methylamino)-2-hydroxybenzoic Acid as a β3-adrenoreceptor Agonist Exerting Anti-obesity, Anti-inflammatory and Hepatoprotective Effects on Zucker Rats." PLoS ONE, vol. 21, no. 3, 2026, p. 1, https://doi.org/10.1371/journal.pone.0344359.